Skip to content

Validation of a German version of the Validierung General attitude towards medication questionnaire (GAM-Q) in patients with prostate cnacer

Validation of a German version of the Validierung General attitude towards medication questionnaire (GAM-Q) in patients with prostate cnacer - GAM-Q_German

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022398
Enrollment
120
Registered
2020-08-13
Start date
2020-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: The patients fill out the german version of the GAM - Q before their prostatectomy. They also answer questions on their general well being, attitude towards medication (beliefs about medicati

Sponsors

Bereichs Schmerzmedizin und SchmerzpsychologieUniversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: prostatectomy >=18 years of age sufficient german language skills patient can give consent (i.e. no dementia, that hinders consent)

Exclusion criteria

Exclusion criteria: severe acute or chronic psychiatric disease (i.e. acute psychotic episode) cognitive impairment (i.e. impaired planing skills, impaired memory)

Design outcomes

Primary

MeasureTime frame
The GAM-Q items will be evaluated. Inverted items will be changed accordingly. A principal component analysis will be conducted and subscales claculated. It will be tested wether the resulting subscales of items in this study correlates significantly with the results in other translations (Tekampe et. al. 2019). The data will be collected before the prostectomy via questionnaire.

Secondary

MeasureTime frame
The secondary outcome is the convergent validity. The total score of the GAM-Q will be correlated with the total score of the BM-Q. This correlation will be tested for significant difference with the corrleation reported in the work of Tekampe et. al. 2019. The data will be collected before the prostectomy via questionnaire.

Countries

Germany

Contacts

Public ContactRegine Klinger

Bereichs Schmerzmedizin und SchmerzpsychologieUniversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie

r.klinger@uke.de040 741052837

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026